State of Wisconsin Investment Board’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.69M Buy
50,946
+25,072
+97% +$1.03M 0.01% 1288
2025
Q4
$1.05M Sell
25,874
-19,608
-43% -$453K ﹤0.01% 1660
2025
Q3
$342K Buy
+45,482
New +$290K ﹤0.01% 2059
2025
Q2
Sell
-41,502
Closed -$115K 2414
2025
Q1
$115K Buy
41,502
+14,683
+55% +$60K ﹤0.01% 2164
2024
Q4
$149K Buy
+26,819
New +$182K ﹤0.01% 2163
2023
Q3
Sell
-36,464
Closed -$319K 2586
2023
Q2
$319K Buy
+36,464
New +$425K ﹤0.01% 1976

Other funds holding TERN

State of Wisconsin Investment Board's TERN Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Terns Pharmaceuticals (TERN) stake by 97% in Q1 2026, buying an estimated $1.03M and bringing the position to 50,946 shares worth $2.69M. The position accounts for 0.01% of the portfolio, ranked #1288.

State of Wisconsin Investment Board first reported a position in TERN in Q2 2023 and has held it in 6 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • State of Wisconsin Investment Board held 50,946 shares of Terns Pharmaceuticals worth $2.69M as of Q1 2026.
  • State of Wisconsin Investment Board bought 25,072 Terns Pharmaceuticals shares in Q1 2026, an estimated $1.03M.
  • Terns Pharmaceuticals made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1288 holding.
  • State of Wisconsin Investment Board first reported a position in Terns Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.